Obesity, Morbid
359
66
85
173
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Published Results
24 trials with published results (7%)
Research Maturity
173 completed trials (48% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.6%
13 terminated out of 359 trials
93.0%
+6.4% vs benchmark
5%
18 trials in Phase 3/4
14%
24 of 173 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 173 completed trials
Clinical Trials (359)
Multimodal Analgesia Effect on Post Surgical Patient
Biometabolic Outcomes After Weight Loss Surgery: An Individualized Approach
The UFO (Ultra Processed Foods in Obesity) Project
Postoperative Nausea, Vomiting and Pain After Bariatric Surgery - a National Registry Study
Brown Adipose Tissue Activation by Spinal Cord Stimulation
AJYR+GV vs RYGB for GERD
Bariatric Surgery and Pharmacokinetics of Paracetamol
Bariatric Surgery and Pharmacokinetics of Metoprolol
Bariatric Surgery and Pharmacokinetics of Valsartan
Bariatric Surgery and Pharmacokinetics of Lamotrigine
Bariatric Surgery and Pharmacokinetics of Losartan
Postextubation Use of Noninvasive Respiratory Support in Severely Obese Patients
Impact of MBS on Body Composition, Basal Metabolic Rates and Muscle Functions in Morbid Obese Patients
Responsive Neurostimulation For Loss Of Control Eating
Flow-Controlled vs Volume-Controlled Ventilation in Morbidly Obese Patients Undergoing Laparoscopic Bariatric Surgery
Investigating Metabolic, Brain, and Cognitive Alterations Through Bariatric Surgery
Bariatric Surgery and Pharmacokinetics of Irbesartan
Bariatric Surgery and Pharmacokinetics of Ibuprofen
Bariatric Surgery and Pharmacokinetics of Lercanidipine
Bariatric Surgery and Pharmacokinetics of Hydrochlorothiazide